Sila Realty Trust (SILA) Q1 2025 earnings summary

Executive summary

• Delivered solid Q1 2025 results with 136 properties, 96.0% leased, and a 9.7-year weighted average lease term, maintaining strong in-place tenancy and high tenant EBITDA coverage.

• Net income attributable to common stockholders was $7.1M, down from $15.0M in Q1 2024, reflecting lower lease termination and severance fee income.

• Focused on healthcare real estate, benefiting from demographic trends and non-discretionary demand, positioning the portfolio as a stable, necessity-based investment amid economic uncertainty.

• Acquired two inpatient rehab facilities for $58.8M in Knoxville, TN and Dover, DE, expanding into new states.

• Listed on the NYSE on June 13, 2024, impacting calculation of net debt leverage ratio.

Financial highlights

• Rental revenue for Q1 2025 was $48.3M, down from $50.6M in Q1 2024, mainly due to lower lease termination income and property sales.

• Cash NOI for Q1 2025 was $41.2M, up 0.5% sequentially but down year-over-year due to non-recurring fees and tenant bankruptcies.

• AFFO was $29.4M ($0.53/share), with a payout ratio of 76.4% for the quarter.

• EBITDAre for Q1 2025 was $36.5M, down from $39.1M in Q1 2024.

• Cash NOI margin was 85.3% for Q1 2025, compared to 92.7% in Q1 2024.

Outlook and guidance

• Targeting $150M–$250M in annual acquisitions under normal conditions; $59M acquired YTD.

• Cautious acquisition pace until share price recovers; not planning to reach high leverage targets in current market.

• Management expects sufficient liquidity for the next twelve months, supported by operating cash flows and available credit.

• Expect both mezzanine loans to be fully funded in Q3 2025.

• Quarterly dividend of $0.40 per share authorized for Q2 2025.